Correlation Between Bone Biologics and Sonnet Biotherapeutics

Can any of the company-specific risk be diversified away by investing in both Bone Biologics and Sonnet Biotherapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bone Biologics and Sonnet Biotherapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Bone Biologics Corp and Sonnet Biotherapeutics Holdings, you can compare the effects of market volatilities on Bone Biologics and Sonnet Biotherapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bone Biologics with a short position of Sonnet Biotherapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bone Biologics and Sonnet Biotherapeutics.

Diversification Opportunities for Bone Biologics and Sonnet Biotherapeutics

-0.75

Correlation Coefficient

Bone Biologics  Sonnet Biotherapeutics

Pay attention - limited upside

The 3 months correlation between Bone and Sonnet is -0.75. Overlapping area represents the amount of risk that can be diversified away by holding Bone Biologics Corp and Sonnet Biotherapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sonnet Biotherapeutics and Bone Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bone Biologics Corp are associated (or correlated) with Sonnet Biotherapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sonnet Biotherapeutics has no effect on the direction of Bone Biologics i.e., Bone Biologics and Sonnet Biotherapeutics go up and down completely randomly.

Pair Corralation between Bone Biologics and Sonnet Biotherapeutics

Given the investment horizon of 90 days Bone Biologics Corp is expected to under-perform the Sonnet Biotherapeutics. But the stock apears to be less risky and, when comparing its historical volatility, Bone Biologics Corp is 4.67 times less risky than Sonnet Biotherapeutics. The stock trades about -0.05 of its potential returns per unit of risk. The Sonnet Biotherapeutics Holdings is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  129.00  in Sonnet Biotherapeutics Holdings on May 7, 2025 and sell it today you would earn a total of  152.00  from holding Sonnet Biotherapeutics Holdings or generate 117.83% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	98.39%
Values	Daily Returns

Bone Biologics Corp  vs.  Sonnet Biotherapeutics Holding

Bone Biologics Corp

Risk-Adjusted Performance

Weakest

Over the last 90 days Bone Biologics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in September 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Sonnet Biotherapeutics

Risk-Adjusted Performance

Fair

Compared to the overall equity markets, risk-adjusted returns on investments in Sonnet Biotherapeutics Holdings are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Sonnet Biotherapeutics displayed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Bone Biologics and Sonnet Biotherapeutics

The main advantage of trading using opposite Bone Biologics and Sonnet Biotherapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bone Biologics position performs unexpectedly, Sonnet Biotherapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sonnet Biotherapeutics will offset losses from the drop in Sonnet Biotherapeutics' long position.

The idea behind Bone Biologics Corp and Sonnet Biotherapeutics Holdings pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.